Evidence for a newly discovered cellular anti-HIV-1 phenotype

Nature Medicine

Volumn 4, Issue 12, 1998, Pages 1397-1400

  Simon, James H M ^a   Gaddis, Nathan C ^a   Fouchier, Ron A M ^a   Malim, Michael H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTIVITY;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; GENE PRODUCTS, VIF; HIV-1; HUMANS; IMMUNITY, NATURAL; PHENOTYPE; T-LYMPHOCYTES; VIRAL REGULATORY PROTEINS; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031788565     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/3987     Document Type: Article

References (38)

1. Sleeves, R. & Lilly, F. Interactions between host and viral genomes in mouse leukemia. Ann. Rev. Genet. 11, 277-296 (1977).
2. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).
3. Samson, M. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725 (1996).
4. Smith, M. et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277, 959-965 (1997).
5. Winkler, C. et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279, 389-393 (1998).
6. Simon, J. H. M. et al. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17, 1259-1267 (1998).
7. Fisher, A. G. et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888-893 (1987).
8. Strebel, K. et al. The HIV "A" (sor) gene product is essential for virus infectivity. Nature 328, 728-730 (1987).
9. + T lymphocytes. J. Virol. 66, 6489-6495 (1992).
10. von Schwedler, U., Song, J., Aiken, C. & Trono, D. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67, 4945-4955 (1993).
11. Tomonaga, K. et al. Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66, 6181-6185 (1992).
12. Simon, J.H.M., Southerling, T.E., Peterson, J.C., Meyer, B.E. & Malim, M.H. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69, 4166-4172 (1995).
13. Reddy, T.R. et al. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J. Virol. 69, 3549-3553 (1995).
14. Harmache, A. et al. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 224, 246-255 (1996).
15. Desrosiers, R. C. et al. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72, 1431-1437 (1998).
16. Fan, L. & Peden, K. Cell-free transmission of Vif mutants of HIV-1. Virology 190, 19-29 (1992).
17. Sakai, H. et al. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67, 1663-1666 (1993).
18. Sova, P. & Volsky, D.J. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67, 6322-6326 (1993).
19. Simon, J.H.M. & Malim, M.H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70, 5297-5305 (1996).
20. Fouchier, R.A.M., Simon, J.H.M., Jaffe, A.B. & Malim, M.H. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-and env-encoded proteins. J. Virol. 70, 8263-8269 (1996).
21. - human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 71, 2473-2477 (1997).
22. Mèvel-Ninio, M. & Weiss, M.C. Immunofluorescence analysis of the time-course of extinction, reexpression, and activation of albumin production in rat hepatoma-mouse fibroblast heterokaryons and hybrids. J. Cell. Biol. 90, 339-350 (1981).
23. Beggs, A.H., Frisque, R.J. & Scangos, G.A. Extinction of JC virus tumor-antigen expression in glial cell-fibroblast hybrids. Proc. Natl. Acad. Sci. USA 85, 7632-7636 (1988).
24. Goncalves, J., Korin, Y., Zack, J. & Gabuzda, D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70, 8701-8709 (1996).
25. Simon, J.H.M. et al. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol. 71, 5259-5267 (1997).
26. Marrack, P. & Kappler, J. Subversion of the immune system by pathogens. Cell 76, 323-332 (1994).
27. Smith, G.L. Virus proteins that bind cytokines, chemokines or interferons. Curr. Opin. Immunol. 8, 467-471 (1996).
28. Ploegh, H.L. Viral strategies of immune evasion. Science 280, 248-253 (1998).
29. Moss, B. in Fields Virology (eds Fields, B.N., Knipe, D.M. & Howley, P.M.) 2637-2671 (Lippincott-Raven, Philadelphia, 1996).
30. Bertin, J. et al. Death effector domain-containing herpes-virus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172-1176 (1997).
31. Hu, S., Vincenz, C., Buller, M. & Dixit, V.M. A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272, 9621-9624 (1997).
32. Thome, M. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521 (1997).
33. Katze, M.G. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3, 75-78 (1995).
34. Mathews, M.B. Structure, function and evolution of adenovirus virus-associated RNAs. Curr. Top. Microbiol. Immunol. 199, 173-187 (1995).
35. Best, S., Le Tissier, P., Towers, G. & Stoye, J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382, 826-829 (1996).
36. DesGroseillers, L. & Jolicoeur, P. Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48, 685-696 (1983).
37. Dubay, J.W., Roberts, S.J., Hahn, B.H. & Hunter, E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66, 6616-6625 (1992).
38. Felber, B.K. & Pavlakis, G.N. A quantitative bioassay for HIV-1 based on trans-activation. Science 239, 184-187 (1988).